Currencies:

Weather:

Live
Новости мира
16 October

Webinar “Sputnik V and its significance to India”

Webinar “Sputnik V and its significance to India”


Amid rising numbers of infected COVID-19 in the world the Russian Federation in August has announced the approval of the first vaccine from the coronavirus – "Sputnik V", which is based on vectors of human adenoviruses. Immediately it was heavily criticized by western countries as non-reliable and even dangerous.

However, according to the first review data from the authoritative medical journal "The Lancet", the Russian drug causes the formation of antibodies without serious side effects. The article responds to foreign criticism and provides long-awaited clarity. The Russian scientists' development, which turned out to be the world's first registered coronavirus vaccine, is not only effective but safe. According to the first and second-stage clinical trial results, the scientists didn't find any serious adverse effects from the vaccine regarding any of the evaluated criteria. Not all candidate vaccines can boast of such results, some have noted up to 25% experiencing serious adverse effects.

The Lancet also cites scientific evidence of the Sputnik V vaccine's effectiveness. For example, evidence of the treatment's ability to launch a long-term immune response to the coronavirus in 100% of those vaccinated due to its unique two-stage introduction technology. “The antibody levels in vaccinated volunteers was 1.4-1.5 times higher than in those who had recovered.

Screenshot_29.png

Currently, more than 20 countries are interested in purchasing more than a billion doses of Sputnik V, with the understanding that research on this COVID-19 vaccine is taking place in the UAE, KSA, Brazil, the Philippines and India. Moreover, an agreement has already been established with Dr. Reddy’s Laboratory to produce about 300 million doses and negotiations are underway to gradually increase production capacity.

It is believed in Russia that all countries should have a vaccine based on the human adenovirus vector in their arsenal, which, according to domestic medical experts, is the most effective vaccination technology with excellent safety indicators.

Main speakers:

  • 1. Mr. OLEG N.AVDEEV, Consul General of Russian Federation in Chennai,
  • 2. Dr. RANGA REDDY BURRI, President of Infection control Academy of India,
  • 3. Dr. D.SURESH KUMAR , MD , FNB(Inf. Disease), Consultant Infectious Disease, Apollo Hospitals, Chennai
  • 4. Dr. D.RAJIV RAJ, assistant professor – Department of general surgery, Sri Ramachandra institute of higher education and research, consultant general surgeon – Sri Ramachandra Medical centre,
  • 5. Dr. LALIT LAKHWANI, Head-Clinical Development at Dr. Reddy’s Laboratory,
  • 6. Dr. M.ARUNACHALAM, MD (Minsk), Founder president RMGA and Chairman, Arunvijaya Hospital, Chennai
  • 7. Dr. BABU GANESH, MD (Russia) President, RMGA.

More on the subject
Новости мира
28 October
Latest count of confirmed COVID-19 cases worldwide at 1030 GMT, Oct. 28
Новости мира
28 October
Plenary session
Новости мира
27 October
NASA discovers water on sunlit surface of moon
Новости мира
27 October
Live COVID-19 updates: Argentina's COVID-19 death tally surpasses 29,000
Новости мира
27 October
Dwayne 'The Rock' Johnson suffers face injury during workout
Новости мира
26 October
BRICS women’s business alliance: strengthening female entrepreneurship as key factor for boosting BRICS economic cooperation
More